This class of drugs, initially a breakthrough for diabetes, has rapidly evolved into a cultural phenomenon, with patient usage soaring from 4 million in 2020 to an estimated 30 million by 2026
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
Metabolic dysfunctionassociated steatohepatitis (MASH )
If you want instant change, alternatives may seem stronger
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
Eat Slowly and Stop When Youre Full This might sound straightforward, but it's crucial